TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
TCL Archive Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015. November 23, 2005
TCL Archive DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies July 10, 1992
TCL Archive Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant. January 25, 2002
